Quest Diagnostics (DGX) traded up 0.44 % during a 24 hours period ending at 01:31 AM Central Europe on Wednesday 28th. One Quest Diagnostics stock can currently be bought for about USD 242.56 on popular exchanges. Current supply of Quest Diagnostics stocks is 110.5 mn. Quest Diagnostics has a current market capitalization of USD 26.6 bn and approximately USD 233.1 mn worth of Quest Diagnostics was traded on exchanges in the last 24 hours. Since last month end, Quest Diagnostics has traded 2.24 % up. Simple moving average of last 200 days is at USD 210.77. The highest price of past 52 weeks was recorded at USD 248.84 on 09/21/2026. 52 weeks low was at USD 171.18 on 01/05/2026.
Here is how related stocks have performed in the past 24 hours:
Northern (NTRS) traded up 0.97 % and now trades at USD 170.35. Current market capitalisation for Northern is USD 30.8 bn. Northern has a current price to earnings ratio of 13.23.
Mongodb (MDB) traded up 4.86 % and now trades at USD 389.84. Mongodb has a market capitalisation of USD 30.2 bn. Current price/earnings ratio for Mongodb is 518.56.
Raymond James (RJF) traded up 0.23 % and now trades at USD 158.12. Raymond James has a market capitalisation of USD 30.6 bn. Current price/earnings ratio for Raymond James is 13.79.
Alnylam (ALNY) traded up 1.62 % and now trades at USD 226.67. Alnylam has a market capitalisation of USD 30.3 bn. Current price/earnings ratio for Alnylam is 39.94.
About Quest Diagnostics
Quest Diagnostics Incorporated is a health care provider operating a national network of full-service laboratories, rapid response laboratories, and patient service centers. The company specializes in offering esoteric, routine medical, drugs of abuse, and non-hospital-based anatomic pathology testing services. You can find more information about their offerings on their website, www.questdiagnostics.com , and they are listed on the New York Stock Exchange. Their initial public offering date was December 17, 1996.